David Johnston

Title: David Johnston: Innovator in Pharmaceutical Compounds

Introduction

David Johnston is a notable inventor based in Didcot, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with unique antiviral properties. With a total of 2 patents, his work has the potential to impact the treatment of serious health conditions.

Latest Patents

David Johnston's latest patents include innovative compounds such as indole, azaindole, and related heterocyclic N-substituted piperazine derivatives. These compounds, which include pharmaceutically acceptable salts, exhibit drug and bio-affecting properties. They are particularly noteworthy for their unique antiviral activity, which can be utilized alone or in combination with other antivirals, antiinfectives, immunomodulators, or HIV entry inhibitors. More specifically, his inventions focus on the treatment of HIV and AIDS. Another significant patent involves bis-aryl thiazole derivatives, which are useful in treating or preventing conditions mediated by uncoupling proteins. These compounds are especially relevant for addressing obesity and type II diabetes.

Career Highlights

Throughout his career, David Johnston has worked with prominent companies in the pharmaceutical industry, including Amgen Inc. and Bristol-Myers Squibb Company. His experience in these organizations has contributed to his expertise in developing innovative therapeutic solutions.

Collaborations

David has collaborated with esteemed colleagues such as M Catherine Amaral and Jin-Long Chen. Their combined efforts have further advanced the research and development of pharmaceutical compounds.

Conclusion

David Johnston's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor. His work in developing antiviral compounds and treatments for serious health conditions showcases the importance of innovation in medicine.